Scientific Breakthrough Reveals Core Health Benefits and Mechanisms of Ripened Pu-erh Tea#

Regulating Gut Microecology for Preventive Treatment of Diseases: Core Health Benefits and Mechanisms of Ripened Pu-erh Tea Scientifically Elucidated

Editor's Note: "Weight management," "anti-aging," "gut health," "sleep health," "microplastics," "prepared dishes," "healthy aging," "smart cafeterias," "anti-inflammatory diet," and "immunity"—these were the top ten nutritional buzzwords released at the end of 2025, reflecting the public's focal points and evolving trends in nutrition and health over the past year. Seeing these buzzwords, doesn't it feel somewhat familiar? "Weight management," "anti-aging," "gut health," "sleep health," and "anti-inflammatory diet"—aren't these precisely the core health benefits of our daily companion, ripened Pu-erh tea? Coincidentally, as the year drew to a close, significant progress was made in research on the health mechanisms of ripened Pu-erh tea. A research team led by Professor Zhao Ming from Yunnan Agricultural University, in collaboration with a team led by Researcher Xu Yongquan from the Tea Research Institute of the Chinese Academy of Agricultural Sciences, published a systematic review in the top international food science journal Trends in Food Science & Technology. This review unequivocally elucidates the core mechanism through which ripened Pu-erh tea exerts its health effects—primarily metabolic regulation and maintenance of redox-inflammatory balance—via "gut microecological regulation," providing a modern scientific explanation for its health benefits. The research team systematically reviewed global academic literature from January 1986 to December 2024, conducting an in-depth analysis of 153 English articles, 136 Chinese articles, and 62 Chinese dissertations. They explicitly proposed that the core health benefit of ripened Pu-erh tea lies in regulating the composition of the gut microbiome, thereby improving metabolic homeostasis and redox-inflammatory balance. This conclusion establishes ripened Pu-erh tea as a significant functional beverage with notable potential in the prevention and management of metabolic diseases. To help readers better understand this latest research and scientifically appreciate the health benefits of ripened Pu-erh tea, our journal has invited Professor Zhao Ming to distill the essence of his research findings into this article, hoping it proves helpful.

I. Overview of Research on the Health Effects of Ripened Pu-erh Tea#

Ripened Pu-erh tea, a national geographical indication product, is cherished for its reddish-brown liquor, mellow taste, distinct aged aroma, and effects such as lipid-lowering and weight reduction. However, its core health benefits and scientific mechanisms have long awaited clarification. To address this, the research team systematically reviewed global academic literature from January 1986 to December 2024, covering various spelling variants, and performed an in-depth analysis of 153 English articles, 136 Chinese articles, and 62 Chinese dissertations. Overall, these studies confirm that ripened Pu-erh tea extract (RPTE) and its characteristic chemical components (particularly theabrownins) are multi-target bioactive compounds with a broad range of physiological effects, including metabolic regulation, redox-inflammatory balance, organ protection, antibacterial activity, and anticancer activity.

Research data indicates that ripened Pu-erh tea is particularly outstanding in metabolic regulation. Notably, its lipid-lowering effect is supported by 109 animal studies, 13 clinical trials, and 11 in vitro studies; its glucose-lowering effect is corroborated by 25 animal studies, 7 clinical trials, and 16 in vitro studies. In contrast, research on its effects on uric acid metabolism (4 animal studies) and constipation relief (4 animal studies) is still in preliminary stages.

Antioxidant effects constitute the second major research focus, with 67 in vitro experiments and 22 animal studies validating its free radical scavenging capacity from multiple angles. Anti-inflammatory research includes 20 animal experiments and 8 in vitro studies, but clinical validation needs further progress, with only 3 clinical trials to date. Additionally, studies have uncovered its potential value in emerging areas like anti-aging (4 studies) and anti-allergy (1 study).

Of particular note, 26 animal experiments and 5 clinical trials have confirmed that ripened Pu-erh tea effectively regulates gut microbiota structure, promoting the growth of beneficial bacteria such as Akkermansia, Bifidobacterium, and Lactobacillus, and producing short-chain fatty acids (SCFAs)—"health messengers." These active substances can remotely regulate liver and fat metabolism, promote energy expenditure, while inhibiting the proliferation of harmful bacteria and reducing endotoxin production, thereby improving the gut's oxidative-inflammatory state and enhancing intestinal barrier function. Changes in gut microbiota also modulate bile acid metabolism, subsequently regulating hepatic lipid metabolism.

Further research indicates that based on its combined antioxidant, anti-inflammatory, and gut-regulating capabilities, ripened Pu-erh tea shows broad prospects in organ protection. Currently, evidence is robust for liver protection (16 studies) and nervous system protection (17 studies), with emerging effects on blood pressure regulation and bone health maintenance.

II. Metabolic Regulation#

The lipid-lowering effect is the most extensively studied aspect of ripened Pu-erh tea research, thoroughly validated by numerous in vivo experiments, clinical trials, and in vitro studies. Glucose-lowering effect ranks second in research volume, while investigations into hyperuricemia regulation and constipation relief are relatively fewer.

(A) Regulation of Glucose and Lipid Metabolism

Ripened Pu-erh tea extract and its bioactive components (e.g., theabrownins) exert multi-target enzyme modulation and exhibit activity in regulating glucose and lipid metabolism. In vitro studies show broad inhibitory effects on various digestive enzymes (including α-amylase, α-glucosidase, sucrase, maltase, and lipase) as well as key regulators of lipid metabolism (such as lipoprotein-associated phospholipase A2, 3-hydroxy-3-methylglutaryl coenzyme A reductase, pancreatic lipase, and protein tyrosine phosphatase 1B). At the cellular level, RPTE modulates lipid homeostasis through transcriptional reprogramming: in hepatoma cells, it inhibits adipogenesis-related factors, promotes cholesterol efflux, and activates the AMPK pathway; in adipocytes, it inhibits adipogenic regulators and reduces lipid droplet accumulation.

In various disease animal models (e.g., diet-induced obesity, diabetes, and metabolic syndrome), RPTE and its active components significantly reduce body weight, obesity indices, and pathological fat deposition, while improving overall lipid homeostasis. Simultaneously, it enhances glucose metabolism by improving insulin sensitivity and beta-cell function. Furthermore, studies show its modulatory effect on uric acid metabolism and its ability to promote intestinal transit and peristalsis. Clinical trials have also confirmed the positive effects of RPTE on human metabolism. In both healthy subjects and individuals with metabolic abnormalities, ripened Pu-erh tea or its instant form significantly regulates glucose and lipid metabolism, primarily manifested by reduced or normalized blood cholesterol, triglycerides, and low-density lipoproteins, increased high-density lipoproteins, and stabilized postprandial blood glucose.

(B) Molecular Mechanisms of Ripened Pu-erh Tea Extract in Regulating Glucose and Lipid Metabolism

Synthesizing existing evidence indicates that RPTE systematically regulates glucose-lipid homeostasis through three interconnected mechanisms: modulation of gastrointestinal function, reprogramming of lipid metabolism, and regulation of glucose metabolism.

1. Gastrointestinal Modulation: RPTE inhibits key digestive enzyme activities, delaying the breakdown of carbohydrates and lipids. It also promotes the excretion of lipids and cholesterol via feces, reducing their absorption in the body, thereby lowering postprandial blood glucose and lipid levels.
2. Lipid Metabolism Reprogramming and Hepatic Cholesterol Homeostasis: RPTE upregulates the expression of specific receptors in adipose tissue. In white adipose tissue, it promotes fatty acid oxidation, inhibits adipogenesis, and enhances lipolysis and thermogenesis by activating related signaling pathways. In the liver, RPTE enhances low-density lipoprotein uptake while inhibiting cholesterol synthesis.
3. Glucose Metabolism Regulation: RPTE activates relevant pathways in the liver, inhibiting gluconeogenesis and promoting glucose uptake in peripheral tissues. Additionally, it mitigates inflammation-induced insulin resistance and the adverse effects of lipotoxicity on glucose metabolism. In summary, RPTE constructs a network regulating glucose-lipid homeostasis through multi-target synergy, thereby improving blood lipid profiles and enhancing insulin sensitivity. These regulatory effects on core pathological indicators of metabolic syndrome suggest that ripened Pu-erh tea is a promising adjunctive intervention for preventing metabolic syndrome, potentially achieving the goal of "preventive treatment of diseases."

III. Improvement of Redox-Inflammatory Balance#

Antioxidant effects constitute the second major research focus on ripened Pu-erh tea, primarily assessed through chemical assays and in vivo models. Research on anti-inflammatory mechanisms is mainly conducted in animal systems, with limited validation in in vitro studies and clinical trials. Emerging areas like anti-aging and anti-allergy still require further in-depth exploration.

(A) Chemical Antioxidant Properties

RPTE exhibits multifaceted chemical antioxidant capabilities, including scavenging various free radicals, enhancing total antioxidant capacity, and increasing ferric reducing power. Furthermore, it protects biological macromolecules from oxidative damage and displays some metal ion chelating activity.

(B) Cellular Mechanisms of Antioxidant and Anti-inflammatory Actions

RPTE can directly scavenge intracellular reactive oxygen species and promote the expression of antioxidant enzymes by activating antioxidant pathways such as Nrf2/ARE, thereby enhancing cellular antioxidant defenses. Concurrently, it protects mitochondrial function and maintains cellular energy metabolism stability. In terms of anti-inflammation, RPTE reduces the production of pro-inflammatory cytokines and mediators by inhibiting signaling pathways like NF-κB and MAPK, while promoting the expression of anti-inflammatory factors, further inhibiting monocyte migration and related receptor activation.

(C) Organ-Specific Protection

In animal models, RPTE demonstrates clear protective effects on multiple organ systems. It reduces oxidative damage and inflammatory responses in the liver, enhances intestinal barrier function, and lowers levels of systemic inflammatory markers. These protective effects involve various mechanisms, including inhibiting inflammatory signaling pathways, promoting detoxification processes, and modulating immune responses.

(D) Clinical Validation

Clinical trial results indicate that ripened Pu-erh tea effectively improves the body's oxidative stress and inflammatory state, manifested by reduced oxidative stress indicators and inflammatory marker levels, increased concentrations of anti-inflammatory cytokines, and modulation of immune cell balance. Additionally, it inhibits specific pathological processes, such as smoking-induced foam cell formation. These health benefits primarily stem from its multi-target modulation of redox-inflammatory pathways and the immune system.

IV. Gut Microbiome Modulation#

Gut microbiome modulation is a crucial research direction for RPTE and theabrownins. In healthy avian and mammalian models, RPTE/theabrownins increase the α-diversity of gut microbiota and boost the relative abundance of beneficial bacterial groups (e.g., Bacteroidetes, Lactobacillus, Akkermansia, Bifidobacterium, and SCFA-producing bacteria) while inhibiting the growth of potential pathogens. Notably, in various disease models such as colitis, high-fat diet-induced metabolic disorders, alcohol exposure, antibiotic interference, aging, constipation, and depression, RPTE/theabrownins effectively ameliorate dysbiosis, specifically by reducing pathogen abundance, enriching beneficial flora, and restoring microbial community diversity.

Clinical studies further validate these regulatory effects. Daily consumption of ripened Pu-erh tea by healthy volunteers significantly increases the abundance of beneficial gut bacteria. In prediabetic individuals, intake of ripened Pu-erh tea enhances specific beneficial bacterial groups and butyrate levels, changes closely correlated with improvements in glucose metabolism indicators. Long-term consumption also shifts the gut microbiota structure towards a Bacteroidetes-dominated profile, accompanied by reduced inflammation and enhanced intestinal barrier function.

RPTE exerts systemic effects through bidirectional regulation of the microbiome: enriching beneficial bacteria promotes SCFA production, which in turn enhances intestinal barrier function by upregulating tight junction proteins and activates antioxidant and anti-inflammatory pathways, exemplified by GPR43/109A receptor-dependent Treg/IL-10 expansion. Conversely, inhibiting microbes with bile salt hydrolase (BSH) activity increases conjugated bile acid levels, thereby reducing hepatic lipogenesis and promoting fatty acid β-oxidation. This gut-liver interaction synergizes with gut-brain axis modulation, collectively influencing neurotransmitter balance and neuroinflammatory processes. These gut microbiota-oriented mechanisms work together to ultimately improve the intestinal microenvironment and restore systemic homeostasis.

V. Anticancer and Antibacterial Activities#

The antibacterial properties of RPTE have been validated in microbiological studies, with preliminary evidence also supporting its antimutagenic effects. Anticancer research currently focuses primarily on cell models, with limited in vivo systemic studies. In vitro experiments show that RPTE inhibits the proliferation of various cancer cell lines and induces cell cycle arrest and apoptosis. A few in vivo studies confirm its ability to inhibit oral carcinogenesis, prevent mutations in gastric precancerous lesions, and act as an adjuvant to enhance the efficacy of conventional therapies. Regarding antibacterial activity, RPTE exhibits significant inhibitory effects against various pathogens, including foodborne pathogens, oral pathogens, and plant pathogens.

Furthermore, RPTE targets viral pathogens such as Human Immunodeficiency Virus, Hepatitis B Virus, and Severe Acute Respiratory Syndrome Coronavirus by inhibiting key enzymes. These properties have potential applications in food preservation technology and nanotechnology (e.g., synthesis of silver nanoparticles), further highlighting the multidimensional therapeutic potential of RPTE in biomedicine and industrial fields.

VI. Organ Protection and Other Health Benefits#

Based on its significant antioxidant, anti-inflammatory, and gut microbiota-modulating capacities, RPTE demonstrates multi-organ protective effects in animal experiments and clinical studies, with robust evidence for liver protection and neuroprotection. Evidence for antihypertensive effects is currently limited. Bone protection and detoxification functions require further validation across multiple models, while gastroprotective effects have only preliminary support.

(A) Neuroprotective Properties

RPTE achieves multifaceted neuroprotection by coordinating various molecular pathways. It not only mitigates the progression of specific neurodegenerative diseases and protects nerve cells from oxidative damage but also effectively alleviates neuroinflammation and maintains hippocampal neuron health. Its antiepileptic effect is closely linked to the downregulation of specific receptors. Additionally, in animal models of Alzheimer's and Parkinson's diseases, the extract shows clear protective effects. Moreover, by modulating neurotransmitter levels, RPTE helps restore gut-brain axis homeostasis and exerts preventive effects against depression.

(B) Hepatoprotective and Gastroprotective Effects

Based on its well-established bioactivity, RPTE exhibits significant liver protection in various liver injury models, including drug-induced toxicity, non-alcoholic fatty liver disease, and alcoholic liver injury. Clinical studies also support its gastroprotective effects: the extract alleviates gastrointestinal symptoms, reduces gastric mucosal injury, lowers the recurrence rate of gastroesophageal reflux disease, and inhibits the malignant progression of atrophic gastritis.

(C) Antihypertensive Effects

In ex vivo experiments, RPTE demonstrates a dual effect of inducing vasodilation and modulating cardiac activity. These effects collectively contribute to blood pressure regulation and show improvement of hypertensive states in preclinical models. Notably, the extract enhances the efficacy of specific antihypertensive drugs while exerting cardioprotective functions.

(D) Detoxification

RPTE exerts broad-spectrum detoxification effects through multiple molecular mechanisms, effectively alleviating damage caused by exogenous substances to various body systems. In passive smoking models, it enhances red blood cell function; directly protects endothelial cells from injury; systemically reduces oxidative stress and DNA damage; and alleviates toxicity induced by specific toxins (e.g., clenbuterol). Notably, the extract also inhibits the formation of advanced glycation end-products by chelating harmful substances, thereby reducing renal inflammation.

(E) Improvement of Bone Health

RPTE exhibits effects in protecting bones and maintaining bone metabolic homeostasis. In ovariectomized rat models, the extract effectively inhibits bone loss due to estrogen deficiency and protects trabecular bone microstructure. Furthermore, RPTE and its main active components show inhibitory effects on osteoclastogenesis in both in vivo and in vitro experiments.

(F) Other Benefits

RPTE protects against type IV hypersensitivity reactions by inhibiting specific interleukins. Its diuretic effect is comparable to certain drugs while maintaining potassium balance. Nanostructured RPTE particles show potential for applications in environmental remediation.

VII. Clinical Trials on Ripened Pu-erh Tea#

To date, 23 clinical trials have been collected aiming to evaluate the health effects of ripened Pu-erh tea or its extracts on different populations. In studies on healthy volunteers, intervention dosages varied widely, with observation periods generally lasting several weeks to months. Studies on specific health conditions show positive effects: in prediabetic individuals, regular consumption of specific doses of ripened Pu-erh tea demonstrated clear benefits; several randomized controlled trials on metabolic syndrome indicated that RPTE was more effective than a placebo. Research has further extended to overweight/obese populations, individuals with metabolic abnormalities, and patients with gastrointestinal diseases. These results collectively reveal the extensive health-regulating potential of ripened Pu-erh tea and its extracts. Additionally, the application of ripened Pu-erh tea in other pathological conditions is being explored.

These studies confirm that ripened Pu-erh tea exerts physiological benefits through multiple targets: significantly improving the body's oxidative status (inhibiting LDL oxidation, reducing malondialdehyde levels, increasing superoxide dismutase activity); reducing pro-inflammatory marker levels (such as serum endotoxin, interleukin-6, tumor necrosis factor-α, and T helper 17 cells), while increasing anti-inflammatory cytokine interleukin-10 and regulatory T cell counts; effectively modulating gut microbial composition (increasing abundance of beneficial bacteria like Akkermansia, Lactobacillus, Bifidobacterium, and Faecalibacterium prausnitzii), promoting SCFA production (especially butyrate), closely correlated with decreased BSH activity and increased serum glycine-conjugated bile acid concentrations.

In terms of metabolic regulation, ripened Pu-erh tea lowers fasting and postprandial blood glucose levels, improves insulin sensitivity, promotes incretin secretion; reduces visceral and hepatic fat accumulation, lowers atherogenic lipid parameters (including LDL cholesterol, total cholesterol, triglycerides, and VLDL cholesterol), while increasing HDL cholesterol and adiponectin levels, and exerts hepatoprotective effects by downregulating specific liver markers. Its benefits for specific diseases include: reducing the risk of malignant transformation of atrophic gastritis, decreasing the recurrence of gastroesophageal reflux disease, and inhibiting smoking-induced monocyte surface receptor expression (a process related to atherosclerotic foam cell formation). These findings collectively establish ripened Pu-erh tea as a health beverage that, through pleiotropic mechanisms, can be applied in preventing early-stage metabolic syndrome, embodying the concept of "preventive treatment of diseases."

However, current clinical studies on ripened Pu-erh tea and its extracts have several significant limitations that may affect result reliability: many studies lack rigorous design (e.g., not double-blind or placebo-controlled), increasing bias risk; some trials have small sample sizes (e.g., n < 30), limiting statistical power and generalizability; intervention periods are generally short, making it difficult to fully assess long-term effects and safety; there is considerable heterogeneity in intervention forms and dosages, complicating cross-study comparisons; furthermore, most studies lack in-depth exploration of underlying mechanisms (e.g., effects on gut microbiota or metabolic pathways), leaving explanatory gaps between observed effects and physiological mechanisms.

VIII. Conclusions and Future Perspectives#

This systematic review synthesizes nearly four decades of research on ripened Pu-erh tea, clarifying that its core health mechanism lies in modulating the colonic microbiome, thereby restoring and maintaining metabolic homeostasis and redox-inflammatory balance. Its key pathways of action include: inhibiting digestive enzyme activity, promoting fecal excretion of lipids and bile acids, and reshaping gut microbiota structure—specifically by reducing the Firmicutes/Bacteroidetes ratio while increasing the abundance of beneficial bacteria like Akkermansia, Bifidobacterium, and Lactobacillus. These changes increase SCFA levels, reduce bacterial endotoxin (lipopolysaccharide) levels, thereby improving the gut's local redox and inflammatory state (manifested as increased superoxide dismutase and glutathione, decreased malondialdehyde, and reduced inflammatory markers like NF-κB, IL-6, and TNF-α), and enhancing intestinal barrier function.

These improvements in the gut extend to the liver via the gut-liver axis, normalizing hepatic redox and inflammatory states. Furthermore, microbiota remodeling reduces BSH activity, alters the bile acid profile, and subsequently activates the intestinal farnesoid X receptor-fibroblast growth factor 15 axis, promoting hepatic fat catabolism. At the systemic level, SCFAs activate peroxisome proliferator-activated receptor gamma (PPARγ) and AMPK pathways in the liver and adipose tissue.

In the liver, this activation inhibits lipogenesis (reducing SREBP-1c and FAS expression), enhances fatty acid β-oxidation (increasing CPT1α and ACOX1 levels), and improves glucose metabolism by promoting glycogen synthesis (increasing glucokinase, pyruvate kinase, and glycogen synthase activities) and inhibiting gluconeogenesis (reducing glucose-6-phosphatase activity).

In adipose tissue, PPARγ activation promotes white adipose tissue browning, enhances fatty acid β-oxidation, and increases thermogenic capacity (increasing UCP1 expression), thereby improving insulin sensitivity. The improvement in hepatic glucose metabolism further promotes glucose uptake in skeletal muscle via the GLUT4 pathway.

As evidence supporting the health benefits of ripened Pu-erh tea accumulates, there is an urgent need to establish synergistic research strategies to facilitate the translation of findings into clinical applications and functional products. To address critical knowledge gaps and advance the field, future research should focus on the following interconnected priorities:

First, conducting large-scale, rigorously designed clinical trials is crucial. Although existing data are promising, long-term, multicenter, randomized controlled trials are needed to clarify the efficacy and safety of ripened Pu-erh tea in populations such as those with prediabetes, obesity, metabolic syndrome, or non-alcoholic fatty liver disease. These trials should include detailed dose-response assessments to optimize intervention strategies. Concurrently, analyzing inter-individual differences in gut microbiota composition could help identify subpopulations most likely to benefit, providing a basis for personalized nutritional interventions.

Second, elucidating the relationship between the structural characteristics of ripened Pu-erh tea's bioactive components and their mechanisms of action remains a fundamental scientific challenge. Theabrownins, recognized as key functional components, are structurally complex high-molecular-weight polymers whose precise chemical structures, structure-activity relationships, and in vivo metabolic processes remain unclear. This knowledge gap limits a deeper understanding of relevant bioactive mechanisms. Therefore, future research should integrate advanced analytical techniques like high-resolution mass spectrometry and nuclear magnetic resonance with functional evaluation systems to systematically analyze the mechanisms by which theabrownins and other less-studied components (such as tea polysaccharides and polyphenol derivatives) affect host physiology. Combining molecular interaction analyses, cell models, and germ-free animal studies could help establish causal mechanisms involving microbial metabolites (e.g., SCFAs, secondary bile acids) interacting with host receptors to regulate metabolism, immunity, and intestinal barrier function.

Finally, translating fundamental research into practical health solutions requires reliance on standardized and innovative product development systems. Currently, the lack of unified classification standards, processing specifications, and quantitative detection methods for bioactive components severely impacts the reproducibility of research and comparability across studies. Establishing generally accepted quality benchmarks for ripened Pu-erh tea is crucial. Simultaneously, efforts should focus on developing innovative formulations with higher bioavailability, such as functional foods or dietary supplements targeting metabolic health and gastrointestinal function. Only by clarifying the active components and their mechanisms of action can a solid scientific foundation be laid for the evidence-based application of ripened Pu-erh tea in nutrition and preventive medicine.